Indeed, peripheral pharmacological blockade or genetic disruption of TPH is protective against obesity and the development of diabetes in high fat diet-fed mice [20,25], highlighting a role for peripheral 5-HT in obesogenic processes. This evidence concerns the gene TPH1 and obesity due to melanocortin 4 receptor deficiency.